ホーム>>Signaling Pathways>> Immunology/Inflammation>> Gastric Disease>>N-acetyl-5-Aminosalicylic Acid

N-acetyl-5-Aminosalicylic Acid (Synonyms: Acetylmesalazine, N-acetyl-ASA, N-acetyl Mesalamine, NSC 54183, Salicytamide)

カタログ番号GC40298

N-アセチル-5-アミノサリチル酸は、抗炎症剤である5-アミノサリチル酸およびそのプロドラッグ形態であるスルファサラジンの代謝物です。

Products are for research use only. Not for human use. We do not sell to patients.

N-acetyl-5-Aminosalicylic Acid 化学構造

Cas No.: 51-59-2

サイズ 価格 在庫数 個数
25mg
$60.00
在庫あり
50mg
$97.00
在庫あり
100mg
$168.00
在庫あり
250mg
$361.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-acetyl-5-Aminosalicylic acid is a metabolite of the anti-inflammatory agent 5-aminosalicylic acid and its prodrug form, sulfasalazine . It is formed in the liver, intestinal lumen, and colonic epithelial cells via N-acetyltransferases. It reduces IFN-γ binding to colonic epithelial cells by 24% when used at a concentration of 10 mM. N-acetyl-5-Aminosalicylic acid (100 µM) scavenges 2,2-diphenyl-1-picrylhydrazyl radicals in a cell-free assay and inhibits base hydroxylation in DNA stimulated by hydroxy radicals. Unlike sulfasalazine, N-acetyl-5-aminosalicylic acid does not inhibit 15-hydroxy prostaglandin dehydrogenase (PGDH). Urinary levels of N-acetyl-5-aminosalicylic acid have been used as a marker of 5-ASA adherence in patients with inflammatory bowel disease.

レビュー

Review for N-acetyl-5-Aminosalicylic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 4 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N-acetyl-5-Aminosalicylic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.